Healthcare & Life Sciences News and Articles

Google News – FDA (biotech/pharma) External News

FDA Approves PharmaEssentia’s BESREMi for Adults With Essential Thrombocythemia - Oncodaily

news.google.com · 01 Sep 2026

Google News – FDA (biotech/pharma) External News

B. Braun adds to a string of IV solution recalls in US - fiercepharma.com

news.google.com · 31 Aug 2026

Google News – Biopharma External News

Redhill Biopharma Stock Doubles In One Session — Here's Why - Benzinga

news.google.com · 31 Aug 2026

Google News – Biopharma External News

Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions - guardonline.com

news.google.com · 31 Aug 2026

Google News – Biopharma External News

Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions - FinancialContent

news.google.com · 31 Aug 2026

Google News – Biopharma External News

Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions - Yahoo Finance

news.google.com · 31 Aug 2026

Google News – Biopharma External News

Quantum BioPharma stock initiated with buy rating at Rodman & Renshaw - Investing.com India

news.google.com · 31 Aug 2026

Google News – Biopharma External News

Seaport Therapeutics to Present at Citi’s 2026 Biopharma Back to School Conference and Participate in 21 - Business Wire

news.google.com · 31 Aug 2026

Google News – Pharmaceuticals External News

Teva Pharmaceuticals to acquire BioXcel assets for up to $125m - finance.yahoo.com

news.google.com · 31 Aug 2026

Google News – Biopharma External News

BPI eBook: Tech Transfer in a Digitalizing Biopharma Industry - BioProcess International

news.google.com · 31 Aug 2026

Industry News External News

Forget GLP-1 stocks, baldness drugs are Wall Street’s next gold mine - The Japan Times

news.google.com · 31 Aug 2026

Google News – FDA (biotech/pharma) External News

Cipla Pharma license cancellation: FDA withdraws order after HC raps it for going 'overboard' - pharma.economictimes.indiatimes.com

news.google.com · 31 Aug 2026

Google News – Pharmaceuticals External News

Arrowhead Pharmaceuticals Presents Phase 3 SHASTA-3 and SHASTA-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia - Arrowhead Pharmaceuticals, Inc.

news.google.com · 30 Aug 2026

Google News – Pharmaceuticals External News

Arrowhead Pharmaceuticals Presents Phase 3 SHASTA-3 and SHASTA-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia - Yahoo Finance

news.google.com · 30 Aug 2026

Google News – EMA (biotech/pharma) External News

EMA Flags Schizophrenia Drug Paliperidone Shortage in EU States Over Pharmathen Manufacturing Issues - Medical Dialogues

news.google.com · 30 Aug 2026

News & Articles

The Workload-to-Role Map: Hiring for Healthcare’s Real Work

The CMC Bridge: Careers That Connect Molecules to Manufacturing

Letby hospital consultant says inquiry makes for grim reading

Safety risk insufficient to show religious accommodation posed undue hardship, court rules

Alleged DEI-motivated hirings and promotions cost Accenture $25M in DOJ settlement

Letby failings go beyond one hospital - the whole system has been found lacking

AI hasn’t significantly improved the speed of hiring, report finds

FDA Launches Expedited IND Pilot, Begins Accepting Applications

Education University PhD student gets 160 hours of community service over doctored reference

Authorities to ‘pursue accountability’ over faulty lifts at Queen Mary Hospital – leader John Lee

The 90-Day Capability Reset for Healthcare Employers

The Decision Architecture Skill Clinical Research Teams Need

Beta Bionics’ insulin patch pump gets FDA nod

HR must set boundaries as it embraces AI notetakers, experts caution

Staff slept while patient killed at NHS mental health unit

Hong Kong parents urged to vaccinate young children amid rising summer flu cases

PEN-Plus operations manual

Human factors isn’t a checkbox: What FDA’s eSTAR requirements mean for MedTech submissions

Responsible spending starts with timely access, informed choices and more connected care

The future of talent sourcing is more than clicks

FDA Approves PharmaEssentia’s BESREMi for Adults With Essential Thrombocythemia - Oncodaily

B. Braun adds to a string of IV solution recalls in US - fiercepharma.com

Redhill Biopharma Stock Doubles In One Session — Here's Why - Benzinga

Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions - guardonline.com

Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions - FinancialContent

Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions - Yahoo Finance

Quantum BioPharma stock initiated with buy rating at Rodman & Renshaw - Investing.com India

Seaport Therapeutics to Present at Citi’s 2026 Biopharma Back to School Conference and Participate in 21 - Business Wire

Teva Pharmaceuticals to acquire BioXcel assets for up to $125m - finance.yahoo.com

BPI eBook: Tech Transfer in a Digitalizing Biopharma Industry - BioProcess International

Forget GLP-1 stocks, baldness drugs are Wall Street’s next gold mine - The Japan Times

Cipla Pharma license cancellation: FDA withdraws order after HC raps it for going 'overboard' - pharma.economictimes.indiatimes.com

Arrowhead Pharmaceuticals Presents Phase 3 SHASTA-3 and SHASTA-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals Presents Phase 3 SHASTA-3 and SHASTA-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia - Yahoo Finance

EMA Flags Schizophrenia Drug Paliperidone Shortage in EU States Over Pharmathen Manufacturing Issues - Medical Dialogues